SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
SNDL Inc.
Financials through fiscal 2026, year ended Dec 31, 2025Last filing: 40-F on Mar 12, 2026
$1.25+0.00 (+0.40%)
Close on Oct 19, 2026
Share price
−$1.08 (−46.14%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SNDL Inc. grew revenue 2.8% to C$946.40M over fiscal 2026. Free cash flow was C$58.11M, up 25.5% from a year earlier.
Revenue
C$946.40M
+2.8% vs. a year earlier
Operating income
-C$6.35M
FY2026
Free cash flow
C$58.11M
+25.5% vs. a year earlier
EPS, diluted
-0.06 CAD
FY2026
Key statistics
Valuation at the latest close; fundamentals over fiscal 2026, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- C$946.40M
- Net income
- -C$15.77M
- EPS, diluted
- -0.06 CAD
- Free cash flow
- C$58.11M
Valuation needs the share price. It fills in once daily prices are connected and converted from CAD.
Nine years at a glance
Fiscal years 2017 to 2026, CAD
Revenue
C$946.40M+2.8% YoY
Gross profit
C$258.65M+7.6% YoY
Operating income
-C$6.35M
Net income
-C$15.77M
EPS, diluted
-0.06 CAD
Free cash flow
C$58.11M+25.5% YoY
Reported period